Investors
Corporate Profile
Elicio Therapeutics is a clinical-stage biotechnology company engineering investigational lymph node-targeted vaccines for an array of aggressive cancers and infectious diseases.
Press Releases
October 16, 2024
September 17, 2024
Events
No events found